{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T17:08:15Z","timestamp":1779124095077,"version":"3.51.4"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2021,2,13]],"date-time":"2021-02-13T00:00:00Z","timestamp":1613174400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,2,13]],"date-time":"2021-02-13T00:00:00Z","timestamp":1613174400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Koninklijke Nederlandse Maatschappij ter bevordering der Pharmacie"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Pharm"],"published-print":{"date-parts":[[2021,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:italic>Background<\/jats:italic>Besides physicians, pharmacy staff has an important role to inform patients on appropriate medication use. However, they might also experience corticophobia themselves, affecting patient counseling and subsequently patient\u2019s disease management.<jats:italic>Objective<\/jats:italic>Implementation of an intervention for pharmacy staff to improve knowledge and stimulate positive perceptions towards TCS use, in order to reduce corticophobia in pharmacy staff and parents of young AD patients.<jats:italic>Setting<\/jats:italic>Nine community pharmacies in the Netherlands.<jats:italic>Method<\/jats:italic>We developed an intervention consisting of education of pharmacy staff followed by counseling of parents. The intervention was implemented in pharmacies and intervention effectiveness was studied using a pre-post design with an intervention period of 3\u00a0months. At baseline and follow-up (3\u00a0months), pharmacy staff and parents completed a questionnaire.<jats:italic>Main outcome measure<\/jats:italic>Corticophobia, both beliefs and worries, measured with the TOPICOP questionnaire. Higher scores indicate a more negative attitude.<jats:italic>Result<\/jats:italic>Baseline and follow-up data were available for 19 pharmacy staff members and 48 parents who attended a counseling session in the pharmacy. In both groups there was as decrease in negative beliefs and worries towards TCS (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05). Mean total TOPICOP scores decreased from 42 to 35% and from 33 to 25% for parents and pharmacy staff respectively.<jats:italic>Conclusion<\/jats:italic>Our results show the prevalence of corticophobia among parents. Education of pharmacy staff and targeted patient counseling seems to be effective in reducing corticophobia.<\/jats:p>","DOI":"10.1007\/s11096-021-01241-2","type":"journal-article","created":{"date-parts":[[2021,2,14]],"date-time":"2021-02-14T13:43:26Z","timestamp":1613310206000},"page":"1237-1244","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Reducing corticosteroid phobia in pharmacy staff and parents of children with atopic dermatitis"],"prefix":"10.1007","volume":"43","author":[{"given":"Ellen S.","family":"Koster","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daphne","family":"Philbert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nila","family":"Moradi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tjalling W.","family":"de Vries","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcel L.","family":"Bouvy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,2,13]]},"reference":[{"key":"1241_CR1","first-page":"240","volume":"57","author":"PC Dirven-Meijer","year":"2014","unstructured":"Dirven-Meijer PC, Kock CA, Nonneman MMG, et al. NHG-standaard eczeem. Huisarts Wet. 2014;57:240\u201352.","journal-title":"Huisarts Wet"},{"issue":"3","key":"1241_CR2","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.aller.2011.02.004","volume":"39","author":"C Flohr","year":"2011","unstructured":"Flohr C. Recent perspectives on the global epidemiology of childhood eczema. Allergol Ummunopathol Madr. 2011;39(3):174\u201382.","journal-title":"Allergol Ummunopathol Madr"},{"key":"1241_CR3","first-page":"CD012119","volume":"2","author":"EJ van Zuuren","year":"2017","unstructured":"van Zuuren EJ, Fedorowicz Z, Christensen R, Lavrijsen A, Arents BWM. Emollients and moisturisers for eczema. Cochrane Database Syst Rev. 2017;2:CD012119.","journal-title":"Cochrane Database Syst Rev."},{"issue":"4","key":"1241_CR4","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1111\/bcpt.13238","volume":"125","author":"A Youngh-Mi","year":"2019","unstructured":"Youngh-Mi A, Hwang A, Jun K, et al. Real-world safety evaluation of topical corticosteroid use: a community pharmacy-based, prospective, observational study. Basic Clin Pharmacol Toxicol. 2019;125(4):405\u201313.","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"1241_CR5","doi-asserted-by":"publisher","first-page":"104878","DOI":"10.1016\/j.phrs.2020.104878","volume":"158","author":"A Chiricozzi","year":"2020","unstructured":"Chiricozzi A, Comberiati P, D\u2019Auria E, Zucottu G, Peroni DG. Topical corticosteroids for pediatric atopic dermatitis: thoughtful tips for practice. Pharmacol Res. 2020;158:104878.","journal-title":"Pharmacol Res"},{"issue":"9","key":"1241_CR6","doi-asserted-by":"crossref","first-page":"13","DOI":"10.5070\/D30Z4408X7","volume":"14","author":"KL Brown","year":"2008","unstructured":"Brown KL, Krejci-Manwaring J, Tusa MG, et al. Poor compliance with topical corticosteroids for atopic dermatitis despite severe disease. Dermatol Online J. 2008;14(9):13.","journal-title":"Dermatol Online J"},{"issue":"2","key":"1241_CR7","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.jaad.2006.05.073","volume":"56","author":"J Krejci-Manwaring","year":"2007","unstructured":"Krejci-Manwaring J, Tusa MG, Carroll C, et al. Stealth monitoring of adherence to topical medication: adherence is very poor in children with atopic dermatitis. J Am Acad Dermatol. 2007;56(2):211\u20136.","journal-title":"J Am Acad Dermatol"},{"issue":"10","key":"1241_CR8","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1001\/jamadermatol.2017.2437","volume":"153","author":"AW Li","year":"2017","unstructured":"Li AW, Yin ES, Antaya R. Topical corticosteroid phobia in atopic dermatitis: a systematic review. JAMA Dermatol. 2017;153(10):1036\u201342.","journal-title":"JAMA Dermatol"},{"key":"1241_CR9","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1080\/09546634.2016.1201189","volume":"28","author":"SM Mueller","year":"2017","unstructured":"Mueller SM, Itin P, Vogt DR, et al. Assessment of \u201ccorticophobia\u201d as an indicator of non-adherence to topical corticosteroids: a pilot study. J Dermatolog Treat. 2017;28:104\u201311.","journal-title":"J Dermatolog Treat"},{"issue":"4","key":"1241_CR10","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1111\/bjd.18455","volume":"182","author":"LC Strowd","year":"2020","unstructured":"Strowd LC, Feldman SR. Overcoming poor adherence is a major hurdle to managing atopic dermatitis. Br J Dermatol. 2020;182(4):836\u20137.","journal-title":"Br J Dermatol"},{"key":"1241_CR11","doi-asserted-by":"publisher","first-page":"871","DOI":"10.2147\/PPA.S36195","volume":"6","author":"AJ Linn","year":"2012","unstructured":"Linn AJ, van Weert JC, Schouten BC, Smit EG, van Bodegraven AA, van Dijk L. Words that make pills easier to swallow: a communication typology to address practical and perceptual barriers to medication intake behavior. Patient Prefer Adherence. 2012;6:871\u201385.","journal-title":"Patient Prefer Adherence"},{"issue":"3","key":"1241_CR12","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1007\/s11096-019-00827-1","volume":"41","author":"ES Koster","year":"2019","unstructured":"Koster ES, Philbert D, Wagelaar KR, Galle S, Bouvy ML. Optimizing pharmaceutical care for pediatric patients with dermatitis: perspectives of parents and pharmacy staff. Int J Clin Pharm. 2019;41(3):711\u20138.","journal-title":"Int J Clin Pharm"},{"issue":"1","key":"1241_CR13","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1111\/pde.13698","volume":"36","author":"B Bos","year":"2019","unstructured":"Bos B, Antonescu I, Osinga H, Veenje S, de Jong K, de Vries TW. Corticosteroid phobia (corticophobia) in parents of young children with atopic dermatitis and their health care providers. Pediatr Dermatol. 2019;36(1):100\u20134.","journal-title":"Pediatr Dermatol"},{"issue":"11","key":"1241_CR14","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.2340\/00015555-3220","volume":"99","author":"L Lambrechts","year":"2019","unstructured":"Lambrechts L, Gilissen L, Morren MA. Topical corticosteroid phobia among healthcare professionals using the TOPICOP Score. Acta Derm Venereol. 2019;99(11):1004\u20138.","journal-title":"Acta Derm Venereol"},{"issue":"2","key":"1241_CR15","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.aller.2018.05.007","volume":"47","author":"S Veenje","year":"2019","unstructured":"Veenje S, Osinga H, Antonescu I, Bos B, de Vries TW. Focus group parental opinions regarding treatment with topical corticosteroids on children with atopic dermatitis. Allergol Immunopathol (Madr). 2019;47(2):166\u201371.","journal-title":"Allergol Immunopathol (Madr)"},{"issue":"4","key":"1241_CR16","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1007\/s11096-014-9954-5","volume":"36","author":"ES Koster","year":"2014","unstructured":"Koster ES, Blom L, Philbert D, Rump W, Bouvy ML. The Utrecht Pharmacy Practice network for Education and Research: a network of community and hospital pharmacies in the Netherlands. Int J Clin Pharm. 2014;36(4):669\u201374.","journal-title":"Int J Clin Pharm"},{"issue":"10","key":"1241_CR17","doi-asserted-by":"publisher","first-page":"e76493","DOI":"10.1371\/journal.pone.0076493","volume":"8","author":"L Moret","year":"2013","unstructured":"Moret L, Anthoine E, Aubert-Wastiaux H, et al. TOPICOP\u00a9: a new scale evaluating topical corticosteroid phobia among atopic dermatitis outpatients and their parents. PLoS ONE. 2013;8(10):e76493.","journal-title":"PLoS ONE"},{"key":"1241_CR18","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1001\/archderm.140.12.1513","volume":"140","author":"CR Charman","year":"2004","unstructured":"Charman CR, Venn AJ, Williams HC. The patient-oriented eczema measure: development and initial validation of a new tool for measuring atopic eczema severity from the patients\u2019 perspective. Arch Dermatol. 2004;140:1513\u20139.","journal-title":"Arch Dermatol"},{"issue":"1","key":"1241_CR19","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1111\/pde.13991","volume":"37","author":"K Capozza","year":"2020","unstructured":"Capozza K, Schwartz A. Does it work and is it safe? Parents\u2019 perspectives on adherence to medication for atopic dermatitis. Pediatr Dermatol. 2020;37(1):58\u201361.","journal-title":"Pediatr Dermatol"},{"issue":"1","key":"1241_CR20","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1177\/1203475419871050","volume":"24","author":"MC Johnson","year":"2020","unstructured":"Johnson MC, Pona A, Adler-Neal AL, Kesty C, Cline A, Feldman SR. Assessing the effect of clinical trial evidence and anecdote on caregivers\u2019 willingness to use corticosteroids: a randomized controlled trial [formula: see text]. J Cutan Med Surg Jan\/Feb. 2020;24(1):17\u201322.","journal-title":"J Cutan Med Surg Jan\/Feb"},{"issue":"12","key":"1241_CR21","doi-asserted-by":"publisher","first-page":"e80633","DOI":"10.1371\/journal.pone.0080633","volume":"8","author":"R Horne","year":"2013","unstructured":"Horne R, Chapman SC, Parham R, Freemantle N, Forbes A, Cooper V. Understanding patients\u2019 adherence-related beliefs about medicines prescribed for long-term conditions: a meta-analytic review of the necessity-concerns framework. PLoS ONE. 2013;8(12):e80633.","journal-title":"PLoS ONE"},{"issue":"5","key":"1241_CR22","doi-asserted-by":"publisher","first-page":"499","DOI":"10.5021\/ad.2015.27.5.499","volume":"27","author":"JY Lee","year":"2015","unstructured":"Lee JY, Her Y, Kim CW, Kim SS. Topical corticosteroid phobia among parents of children with atopic eczema in Korea. Ann Dermatol. 2015;27(5):499\u2013506.","journal-title":"Ann Dermatol"},{"key":"1241_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.sapharm.2020.09.009","author":"M Ceulemans","year":"2020","unstructured":"Ceulemans M, Liekens S, van Calsteren K, Allegaert K, Foulon V. Impact of a blended learning program on community pharmacists\u2019 barriers, knowledge, and counseling practice with regard to preconception, pregnancy and lactation. Res Social Adm Pharm. 2020. https:\/\/doi.org\/10.1016\/j.sapharm.2020.09.009.","journal-title":"Res Social Adm Pharm"},{"key":"1241_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.pec.2020.09.018","author":"SJ Showande","year":"2020","unstructured":"Showande SJ, Edidion NO. Impact of pharmacists\u2019 training on oral anticoagulant counseling: a randomized controlled trial. Patient Educ Couns. 2020. https:\/\/doi.org\/10.1016\/j.pec.2020.09.018.","journal-title":"Patient Educ Couns"},{"key":"1241_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5688\/ajpe767131","volume":"76","author":"JN Battaglia","year":"2012","unstructured":"Battaglia JN, Kieser MA, Bruskiewitz RH, Pitterle ME, Thorpe JM. An online virtual-patient program to teach pharmacists and pharmacy students how to provide diabetes-specific medication therapy management. Am J Pharm Educ. 2012;76:1.","journal-title":"Am J Pharm Educ"},{"issue":"1","key":"1241_CR26","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.pec.2013.09.023","volume":"94","author":"S Liekens","year":"2014","unstructured":"Liekens S, Vandael E, Roter D, Larson S, Smits S, Laekeman G, Foulon V. Impact of training on pharmacists\u2019 counseling of patients starting antidepressant therapy. Patient Educ Couns. 2014;94(1):110\u20135.","journal-title":"Patient Educ Couns"},{"issue":"7","key":"1241_CR27","doi-asserted-by":"publisher","first-page":"e0236797","DOI":"10.1371\/journal.pone.0236797","volume":"15","author":"MJ Kang","year":"2020","unstructured":"Kang MJ, Park JH, Park S, et al. Community pharmacists\u2019 knowledge, perceptions, and practices about topical corticosteroid counseling: a real-world cross-sectional survey and focus group discussions in Korea. PLoS ONE. 2020;15(7):e0236797.","journal-title":"PLoS ONE"},{"issue":"11","key":"1241_CR28","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1111\/all.13189","volume":"72","author":"JF Stalder","year":"2017","unstructured":"Stalder JF, Aubert H, Anthoine E, et al. Topical corticosteroid phobia in atopic dermatitis: international feasibility study of the TOPICOP score. Allergy. 2017;72(11):1713\u20139.","journal-title":"Allergy"},{"issue":"4","key":"1241_CR29","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1111\/ijd.14289","volume":"58","author":"AB Fleischer Jr","year":"2019","unstructured":"Fleischer AB Jr. Atopic dermatitis: the relationship to temperature and seasonality in the United States. Int J Dermatol. 2019;58(4):465\u201371.","journal-title":"Int J Dermatol"},{"issue":"3","key":"1241_CR30","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1111\/j.0022-202X.2005.23625.x","volume":"124","author":"U Kr\u00e4mer","year":"2005","unstructured":"Kr\u00e4mer U, Weidinger S, Darsow U, M\u00f6hrenschlager M, Ring J, Behrendt H. Seasonality in symptom severity influenced by temperature or grass pollen: results of a panel study in children with eczema. J Investig Dermatol. 2005;124(3):514\u201323.","journal-title":"J Investig Dermatol"}],"container-title":["International Journal of Clinical Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-021-01241-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11096-021-01241-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-021-01241-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T09:23:19Z","timestamp":1671268999000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11096-021-01241-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,13]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["1241"],"URL":"https:\/\/doi.org\/10.1007\/s11096-021-01241-2","relation":{},"ISSN":["2210-7703","2210-7711"],"issn-type":[{"value":"2210-7703","type":"print"},{"value":"2210-7711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,13]]},"assertion":[{"value":"4 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}}]}}